CALA — Calithera Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Calithera Biosciences Shares Progress In Sapanisertib And Mivavotinib Clinical Programs
Brief: Calithera Biosciences Announces First Patient Enrolled In Phase 2 Clinical Trial Of Sapanisertib
Brief: Calithera Biosciences Announces First Patient Enrolled In Phase 2 Clinical Trial Of Mivavotinib In Relapsed/Refractory Non-Gcb (Abc) Diffuse Large B-Cell Lymphoma
Brief: Calithera Biosciences Announces 1-For-20 Reverse Stock Split
Calithera Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Calithera Biosciences Inc expected to post a loss of 18 cents a share - Earnings Preview
Calithera Biosciences Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Calithera Biosciences Inc - Got Notice From Nasdaq Notifying That Co Did Not Satisfy Certain Continued Listing Requirement
U.S. RESEARCH ROUNDUP- Albemarle, Okta, Walgreens
Calithera Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Calithera Biosciences Reports Fourth Quarter And Full Year 2021 Financial Results And Recent Highlights
U.S. STOCKS ON THE MOVE-Inspirato Inc, PVH Corp, Whirlpool Corp
U.S. STOCKS ON THE MOVE-Nvidia Corp, BioNTech SE, Adagio Therapeutics Inc
U.S. STOCKS ON THE MOVE-Pearson PLC, BioNTech SE, Robinhood Markets
Calithera Biosciences slides on stock-and-warrants offering
Brief: Calithera Biosciences Inc. Says Pricing Of Its Public Offering Of 18,518,519 Shares Of Its Common Stock At A Price Of $0.54 Per Share
Calithera Biosciences Inc expected to post a loss of 24 cents a share - Earnings Preview
Calithera Biosciences Inc expected to post a loss of 24cents a share - Earnings Preview
Calithera Biosciences Inc expected to post a loss of 24 cents a share - Earnings Preview